Tender detail
Open-house pharmaceutical discount agreements for perampanel
Summary
The procurement concerns non-exclusive pharmaceutical discount agreements for medicines containing the active ingredient perampanel (ATC N03AX22). Agreements may be concluded at any time under the open-house model and cover the period from 1 December 2026 to 30 November 2028. Medicines listed as paediatric medicines under the applicable BfArM list are excluded from the scope.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.